Uniqure NV (NASDAQ:QURE)

41.63
Delayed Data
As of Aug 13
 +0.16 / +0.39%
Today’s Change
36.20
Today|||52-Week Range
76.69
-41.91%
Year-to-Date
Genomic Medicine: Summer 2020 Update
Aug 13 / Seeking Alpha - Paid Partner Content
uniQure EPS misses by $0.31, misses on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
A Quick Investment Idea On uniQure
Jul 30 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close41.53
Today’s open41.63
Day’s range41.21 - 42.12
Volume203,870
Average volume (3 months)534,576
Market cap$1.8B
Data as of 3:59pm ET, 08/13/2020

Growth & Valuation

Earnings growth (last year)-32.84%
Earnings growth (this year)+114.35%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)-35.48%
P/E ratioNM
Price/Sales393.68
Price/Book5.58

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.84+2.58%
MCRBSeres Therapeutics I...+5.02+21.31%
AUPHAurinia Pharmaceutic...-0.01-0.07%
SGMOSangamo Therapeutics...-0.06-0.51%
Data as of 4:47pm ET, 08/13/2020

Financials

Next reporting dateNovember 3, 2020
EPS forecast (this quarter)$2.20
Annual revenue (last year)$7.3M
Annual profit (last year)-$124.2M
Net profit margin-1,705.82%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Amsterdam, Noord-holland

Forecasts